# Contact — the BPC-157 TB-500 Editorial Digest

> Contact the editors of this BPC-157 TB-500 digest. An editorial project summarizing the Wolverine blend literature — not a clinic, not a vendor, and not a source for medical advice.

Editorial correspondence about the research digest — corrections, source suggestions, and questions about how a claim was sourced.

## Editorial correspondence

This BPC-157 TB-500 digest welcomes editorial correspondence. If a citation looks wrong, a study has been superseded, or a finding on a specimen plate deserves a sharper caveat, the message form below reaches the editors.

What we can help with is the record: how a claim was sourced, which study a number came from, and where the literature stops. What we cannot offer is anything resembling care. We do not give medical advice, we do not recommend doses, and we do not sell, supply, or source any peptide. Questions about personal use belong with a licensed healthcare professional, not with an editorial reading room. The aim is a record kept current and honest, one correction at a time.

## What this form is not

The form is not a clinical intake, an order channel, or a consultation request. No prescriber reviews these messages, and no preparation is dispensed from this site. For the regulatory picture on access — including how lawful compounding works and why both constituents currently sit in FDA's 503A Category 2 — see the [Wolverine legal status and 503A category](/legal-status) page.

Good corrections tend to be specific: a citation that no longer resolves, a study that has been superseded, a place where a caveat reads as softer than the underlying source warrants. Those are the notes that improve a reference, and they are the ones we act on fastest. We read what arrives and correct what we get wrong — a cited, careful field-record of the published research on the Wolverine blend, kept honest by the people who write to tell us where it is not.

---

A distilled field-record of the BPC-157 and TB-500 literature — each peptide pressed as its own cited specimen, its 503A access status read first, with no clinic behind the folio and nothing here prescribed or sold.